SCHEMBL30033568

SCHEMBL30033568

O=c1[nH]cc([N+](=O)[O-])c2c(F)cccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ CASP6 P55212 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.43
▸ PARP1 P09874 4/20 0.42
▸ PIM3 Q86V86 1/20 0.40
▸ DNA2 P51530 1/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ GUSB P08236 1/20 0.38
▸ ALOX15 P16050 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ AR P10275 1/20 0.36
▸ GRM6 O15303 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15717048 0.76 ALDH1A1 (0.64) ALDH1A1CASP6TDP1PARP1DNA2
SCHEMBL26691525 0.74 NR4A2 (0.43) ALDH1A1CASP6TDP1PIM3DNA2
SCHEMBL29583090 0.74 NR4A2 (0.43) ALDH1A1CASP6TDP1PIM3DNA2
SCHEMBL19871818 0.73 PARP1 (0.45) ALDH1A1PARP1KDM4EHSD17B10CYP3A4
SCHEMBL3179229 0.71 TDP1 (0.46) ALDH1A1CASP6TDP1PIM3ALOX15
SCHEMBL19449768 0.71 CTSB (0.59) ALDH1A1CASP6TDP1KDM4EALOX15
SCHEMBL29914820 0.71 PARP1 (0.49) ALDH1A1PARP1KDM4EARMAPT
SCHEMBL1126793 0.69 TDP1 (0.75) ALDH1A1TDP1ALOX15HSD17B10CYP3A4
SCHEMBL893998 0.68 TDP1 (0.55) ALDH1A1CASP6TDP1PARP1KDM4E
SCHEMBL30012694 0.68 TDP1 (0.55) ALDH1A1CASP6TDP1PARP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224223-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2022-10-27 — — WO disclosed
Send feedback